ReShape Lifesciences Inc. (RSLS)
0.35
-0.04 (-9.54%)
At close: Mar 31, 2025, 2:20 PM
ReShape Lifesciences Stock Forecast
Stock Price Forecast
The 0 analysts with 12-month price forecasts for RSLS stock have an median target of 0, with a low estimate of 0 and a high estimate of 0. The median target predicts a decrease of 0% from the current stock price of 0.35.
Latest Analyst Insight Report
According to 0 stock analyst, the rating for ReShape Lifesciences Inc. is "undefined". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
9.99M
from 8.68M
Increased by 15.2%
Revenue Next Year
11.99M
from 9.99M
Increased by 20.0%
EPS This Year
-26.1
from -110.88
Increased by 76.5%
EPS Next Year
-20.88
from -26.1
Increased by 20.0%